期刊文献+

药物性角膜病变的临床分析 被引量:11

Clinical analysis of drug toxic keratopathy
下载PDF
导出
摘要 目的:探讨药物性角膜病变的临床特征,以提醒临床医生注意,预防此类疾病的发生。方法:对临床所见24例34眼药物性角膜病变的临床资料进行回顾性总结分析。结果:角膜病变轻者,短期用药即可恢复角膜上皮混浊水肿消退,角膜透明视力增加。角膜病变重用药时间长者,大约2~4wk才可完全恢复。结论:药源性角膜病变多由眼局部不合理用药引起,其临床表现多为非特异性,不同滴眼剂所致角膜毒性的发病机制不尽相同,临床眼科医生应关注滴眼剂对角膜的毒性作用,并积极预防和治疗,规范用药、预防发生是关键。 AIM: To study the clinical features of drug toxic keratopathy so as to raise the attention of doctors on its prevention. METHODS: The clinical data of 24 cases (34 eyes) with drug toxic keratopathy were retrospectively analyzed. RESULTS: The drug toxic keratopathy is mainly caused by improper local drug usage with non-spedfity as its major dinical manifestation. CONCLUSION: Since the mechanisms of keratopathy caused by different drugs vary each other, doctors should pay attention to the toxicity of eye drops on the cornea, and standardized durg usage and proper prevention are the keys to active treatment of the drug toxic keratopathy.
作者 杨小慧
出处 《国际眼科杂志》 CAS 2007年第3期861-862,共2页 International Eye Science
关键词 滴眼剂 药物毒性 角膜病变 eye drop drug toxicity keratopathy
  • 相关文献

参考文献3

二级参考文献24

  • 1Wilson FM. Adverse external ocular effects of topical ophthalmic therapy: an epidemiological, laboratory and clinical study. Trans Am Ophthalmol Soc,1983,81:854-965.
  • 2Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc, 2001,99:205-212.
  • 3Lin JC, Rapuano CJ, Laibson PR, et al. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol,2000,118:1129-1132.
  • 4Pouliquen Y, Patey A, Foster CS,et al. Drug induced cicatrical pemphigoid affecting the conjunctiva. Light and electron microscopic features. Ophthalmology,1986,93:776-783.
  • 5Scuderi AC, Paladino GM, Marino C,et al. In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells. Cornea,2003,22:468-472.
  • 6Mallari PL, McCarty DJ, Daniell M,et al. Increased incidence of corneal perforation after topical fluroquinolone treatment for microbial keratitis. Am J Ophthalmol, 2001,131:131-133.
  • 7Broadway DC, Grierson I, O′Brien C,et al. Adverse effects of topical antiglaucoma medication. Arch Ophthalmol,1994,112:1437-1445.
  • 8Savolainen PS, Jrvinen T, Sasaki KA, et al. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharmaceutical Research,1998,15:1275-1280.
  • 9Schwab IR, Linberg JV, Gioia VM,et al. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology, 1992,99:197-202.
  • 10Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol,2002,86:418-423.

共引文献81

同被引文献60

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部